A Study to Determine the Absorption of Peroral Insulin in Dextran Matrix (ORA3)

Clinical trial NCT01114750 · SUSPENDED

Trial details

NCT number: NCT01114750
Sponsor: Bows Pharmaceuticals AG
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2010-04-01
Primary completion: 2010-08-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.